MeSH D011019 - mycoplasma pneumonia
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Teva | Azithromycin | Azithromycin | 2005-11-14 | |||
| Taro Pharmaceutical | Azithromycin | Azithromycin | 2019-12-11 | |||
| Mylan | Azithromycin | Azithromycin | 2007-05-30 | |||
| Rising Pharmaceuticals | Azithromycin | Azithromycin | 2007-05-30 | |||
| Lupin Research | Azithromycin | Azithromycin | 2015-05-15 | |||
| Sandoz | Azithromycin | Azithromycin | 2005-11-14 | |||
| Pfizer | Azithromycin, Trovafloxacin | Trovan/zithromax Compliance | 1998-12-18 | |||
| Azithromycin | Zithromax | 1991-11-01 | $406 M | Y2023 | ||
| Aurobindo Pharma | Azithromycin | Azithromycin | 2007-01-08 |
1
2
3
4
5
>
Clinical Trials
Historical Success Rate
Phase 1
0%0/0
Phase 2
0%0/0
Phase 3
100%3/3
Approved: 3Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
3
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use